The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
29
1kṀ5413resolved Jan 25
Resolved
NO1H
6H
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Name | Total profit |
|---|---|---|
| 1 | Ṁ304 | |
| 2 | Ṁ148 | |
| 3 | Ṁ82 | |
| 4 | Ṁ81 | |
| 5 | Ṁ31 |
People are also trading
Related questions
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
62% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
7% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will there be a recall of Wegovy/Ozempic before 2035?
80% chance
How many OECD countries will have court ordered semaglutide drugs (e.g., Ozempic) by the end of 2030
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
42% chance
Will the Ozempic shortage be resolved on December 31st, 2025 according to the FDA?
77% chance
Ozempic approval is revoked or withdrawn before 2031
6% chance
When will Hims stop selling semaglutide?